Below are links to the SACT mock prescription verification examples, which are writable PDFs.

Please review the case history details together with the prescription and any other useful references (SPC, local protocols, guidelines etc). Please indicate any prescribing errors and/or interventions that you have identified in the Discussion Points box. These should be discussed with your SACT assessor.

  1. FEC-T/Breast (Nov 2019)
  2. R-CHOP/Non-Hodgkins Lymphoma (Nov 2019)
  3. Docetaxel/Prostate (Nov 2019)
  4. Carbo & Pemetrexed/Lung (Nov 2019)
  5. Capecitabine/Breast (Nov 2019)
  6. Folfiri/Colorectal (Nov 2019)
  7. Daratumumab/Myeloma (Nov 2019)
  8. Ipilimumab & Nivolumab/Melanoma (Nov 2019)
  9. Ifos & dox/Soft tissue sarcoma (Nov 2019)
  10. Folfox & cetux/Colorectal (Nov 2019)
  11. BEACOPP/Hodgkins Lymphoma (Nov 2019)
  12. FEC/Adj breast (Nov 2019)
  13. VCD biweekly/Myeloma (Nov 2019)
  14. Lenalidomide/Myeloma (Nov 2019)
  15. Alectinib/NSC lung (Nov 2019)
  16. Trastuzumab sc/Breast (Nov 2019)
  17. Acc paclitaxel/Breast (Nov 2019)
  18. Cisplatin & pembrolizumab & pemetrexed/Lung (Nov 2019)
  19. Carboplatin & paclitaxel/Gynae (Nov 2019)
  20. Abiraterone/Prostate (Nov 2019)